Short answer
Septerna, Inc. (SEPN) filed its Q1 2026 10-Q quarterly report on May 11, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $27M (up 12011.0% year over year) with net income of −$9M.
Q1 2026 key financials · XBRL
- Revenue
- $27M
- +12011.0% YoY
- Net income
- −$9M
- +59.8% YoY
- Operating margin
- -50.1%
- EPS (diluted)
- −$0.19
- +61.2% YoY
Source: XBRL data from the Septerna, Inc. (SEPN) Q1 2026 10-Q on SEC EDGAR. USD.
Septerna, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No newly added or materially changed risk factors identified versus the 2025 10-K
- Liquidity risk: cash, cash equivalents, and marketable securities totaled $522.1 million as of March 31, 2026
- Clinical development risk: no advanced clinical trials completed, delaying potential commercialization for years
- Regulatory risk: product candidates face extensive approval and compliance requirements that may prevent commercialization
- Operational risk: reliance on third-party manufacturers, CROs, CMOs, and suppliers for development activities
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Septerna, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.